IgA Nephropathy: Impact of EBV Infection on Racial Differences
IgA Nephropathy: Impact of EBV Infection on Racial Differences
批准号:
10429362
负责人:
JIRI F MESTECKY
金额:
$22.28万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-07 至 2024-06-30
关键词:
AborigineAcetylgalactosamineAdolescenceAdultAffectAfricaAfricanAfrican AmericanAfrican American populationAgeAntibodiesAntigen-Antibody ComplexAntigensAsiaAsianAustraliaAutoantigensAutoimmune DiseasesB-LymphocytesBangladeshBiochemicalBlack PopulationsBlack raceBlood CellsBlood CirculationBody FluidsCD19 geneCellsCentral AfricaCharacteristicsChildCountryDepositionDevelopmentDiseaseEpstein-Barr Virus InfectionsEuropeFar EastFrequenciesFutureGalactoseGeographic DistributionGeographyGlomerulonephritisHomingHuman Herpesvirus 4IGA GlomerulonephritisIgA DeficiencyIgA1IgA2Immune responseImmunoglobulin AImmunoglobulin DImmunoglobulin GImmunoglobulin MIn VitroIncidenceIndiaInfectionInterleukin-10InterventionJ-Chain ImmunoglobulinsJapanKidney DiseasesLeukocytesLinkLymphoid TissueMucous MembraneN-terminalNepalNorth AmericaPathologicPatientsPhenotypePlasmaPolymersPolysaccharidesPopulationPrevalencePropertyPubertyReportingSerumSouth AmericanStructure of glomerular mesangiumSurfaceSurface ImmunoglobulinsSystemTimeVaccinesage relatedbaseearly childhoodepidemiologic datain vivolymphoblastmesangial cellmouse modelperipheral bloodpreventracial differencereceptorresidenceseropositivetransforming virus
中文摘要
摘要
IgA肾病是一种自身免疫性疾病,其中只有IgA1亚类的IgA含有
糖链改变的部分,主要是作为一种抗原被自然产生的抗糖链抗体识别
免疫球蛋白同型,导致肾炎免疫复合体的形成。IgA肾病的发病率
显示出很大的地理和种族分布:这种疾病在欧洲、北美、
澳大利亚和选定的亚洲国家(特别是日本),但在中非很少见,在
印度、孟加拉国、尼泊尔和许多南美国家。令人惊讶的是,发音的
与种族相关的发病率下降仍然是个谜。非裔美国人,非裔黑人,
澳大利亚原住民,可能还有一些国家的罗曼人,很少患上IgAN。通过
我们发现,对白人IgAN患者、健康对照组和非裔美国人的血清和细胞进行了分析
产生糖链改变的IgA1的细胞感染了爱泼斯坦-巴尔病毒(EBV),它分泌
在它们的末端分化时,IgA1的糖链部分发生了变化。对于我们的工作假设来说很重要,在
在白人患者的IgA阳性细胞中检测到IgN、EBV感染的细胞,而在健康成年人中检测到
在非裔美国人中,EBV主要与IgM/IGD和IgG阳性的B细胞有关。这样做的原因是
以前被忽视的免疫球蛋白A成熟的差异被揭示出来
与EBV感染的时间有关的系统。血清免疫球蛋白A水平及血清免疫球蛋白A抗体阳性率
产生的细胞严格依赖于年龄。儿童早期(1-5岁)的免疫球蛋白A水平较低
而产生IgA的细胞和成人的水平在青春期达到。然而,非裔美国人,非裔美国人
黑人,澳大利亚原住民在他们生命的头两年感染了EBV。因此,在
自然免疫球蛋白A缺乏的时间,EBV感染“非免疫球蛋白阳性”细胞。事实上,我们报告说,在非洲
美国成年人的EB病毒并不主要存在于IgA细胞中!目前,我们缺少这一信息
关于免疫球蛋白A系统和表型发育成熟的特点
血清阳性非裔美国人与血清阴性白人EB病毒感染细胞的特征比较
孩子们。这些信息对于阐明IgAN和BASIC的免疫发病机制是必不可少的。
澄清与种族有关的差异。因此,我们建议为我们的
工作假设:再障儿童的EBV感染主要限于非SIgA B细胞,因此
阻止IgAN的发展。这将通过确定EBV对
血清阳性和阴性再生障碍性贫血与不同性别白种儿童循环免疫球蛋白A特征
年龄。此外,我们还将确定EBV感染如何影响IgA细胞的表型和归巢潜能
来自血清阳性再生障碍性贫血儿童的外周血液。
英文摘要
ABSTRACT
IgA nephropathy (IgAN) is an autoimmune disease in which IgA exclusively of the IgA1 subclass contains
altered glycan moiety and serves as an antigen recognized by naturally occurring anti-glycan antibodies mostly
of the IgG isotype, leading to the formation of nephritogenic immune complexes. The incidence of IgAN
displays a great geographical and racial distribution: the disease is common in Europe, North America,
Australia and selected Asian countries (especially Japan), but is rare in central Africa and uncommon in
countries such as India, Bangladesh, Nepal and many South American countries. Surprisingly the pronounced
racially-associated decreased incidence of the disease remains enigmatic. African Americans, African Blacks,
Australian Aborigines and probably Romanines in some countries only rarely become ill with IgAN. By
analyses of sera and cells from White IgAN patients, healthy controls and African Americans, we discovered
that the cells producing IgA1 with altered glycans are infected with the Epstein-Barr virus (EBV), which secrete
upon their terminal differentiation, IgA1 with altered glycan moiety. Importantly for our working hypothesis, in
IgAN, EBV-infected cells were detected in the IgA-positive cells from White patients, while in the healthy adult
African Americans, EBV was primarily associated with IgM/IgD and IgG-positive B cells. The reason for this
remarkable disparity was revealed through the previously disregarded difference in the maturation of the IgA
system as related to the timing of EBV infection. The levels of serum IgA and the frequency of the IgA-
producing cells are strictly dependent on the age. Children at the early age (1-5 years) have low levels of IgA
and IgA-producing cells and the adult levels are attained at puberty. However, African Americans, African
Blacks, Australian Aborigines become infected with EBV during the first 2 years of their lives. Therefore, at the
time of natural IgA deficiency, EBV infects “non-IgA-positive” cells. Indeed, we reported that in the African
American adults EBV is not dominantly found in the IgA cells! Currently, we are missing the information
concerning the characteristics of the development and maturation of the IgA system and phenotypic
characteristics of EBV-infected cells in seropositive African Americans as compared to seronegative White
children. This information is essential for the elucidation of the immunopathogenesis of IgAN and basic
clarification of racially-dependent differences. Therefore, we propose to provide experimental evidence for our
working hypothesis that the EBV infection of AA children is mainly restricted to the non-sIgA+ B cells and thus
prevents the development of IgAN. This will be accomplished by determining the differential impact of EBV on
the IgA characteristics in circulation of seropositive and seronegative AA versus White children of different
ages. In addition, we will determine how EBV infection affects the phenotype and homing potential of IgA cells
from peripheral blood of seropositive AA children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IgA Nephropathy: Impact of EBV Infection on Racial Differences
-
批准号:10661504
-
项目类别:
-
资助金额:$9.17万
-
财政年份:2022
-
负责人:JIRI F MESTECKY
-
依托单位:
IgA Nephropathy: Interventions with Generation of Nephritogenic Immune Complexes
-
批准号:8692360
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2014
-
负责人:JIRI F MESTECKY
-
依托单位:
Immunologic Uniqueness of the Female Genital Tract in HIV Pathogenesis
-
批准号:7936217
-
项目类别:
-
资助金额:$198.26万
-
财政年份:2009
-
负责人:JIRI F MESTECKY
-
依托单位:
Immunologic Uniqueness of the Female Genital Tract in HIV Pathogenesis
-
批准号:7680723
-
项目类别:
-
资助金额:$200.02万
-
财政年份:2009
-
负责人:JIRI F MESTECKY
-
依托单位:
Familial IgA Nephropathy: Genetic and Metabolic Studies
-
批准号:6464953
-
项目类别:
-
资助金额:$131.18万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
Familial IgA Nephropathy: Genetic and Metabolic Studies
-
批准号:7008078
-
项目类别:
-
资助金额:$134.71万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
Familial IgA Nephropathy: Genetic and Metabolic Studies
-
批准号:6845694
-
项目类别:
-
资助金额:$134.79万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
Familial IgA Nephropathy: Genetic and Metabolic Studies
-
批准号:6623346
-
项目类别:
-
资助金额:$132.02万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
PERIODONTAL DISEASE:ROLE OF ABERRANT Ig GLYCOSYLATION
-
批准号:6910708
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
Familial IgA Nephropathy: Genetic and Metabolic Studies
-
批准号:6731986
-
项目类别:
-
资助金额:$135.14万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
PERIODONTAL DISEASE:ROLE OF ABERRANT Ig GLYCOSYLATION
-
批准号:6648474
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
PERIODONTAL DISEASE:ROLE OF ABERRANT Ig GLYCOSYLATION
-
批准号:7082809
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
PERIODONTAL DISEASE:ROLE OF ABERRANT Ig GLYCOSYLATION
-
批准号:6542468
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
PERIODONTAL DISEASE:ROLE OF ABERRANT Ig GLYCOSYLATION
-
批准号:6787746
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2002
-
负责人:JIRI F MESTECKY
-
依托单位:
MUCOSAL IMMUNOLOGY LABORATORY
-
批准号:6158937
-
项目类别:
-
资助金额:$25.0万
-
财政年份:1998
-
负责人:JIRI F MESTECKY
-
依托单位:
MUCOSAL IMMUNOLOGY LABORATORY
-
批准号:6333345
-
项目类别:
-
资助金额:$9.98万
-
财政年份:1998
-
负责人:JIRI F MESTECKY
-
依托单位:
MUCOSAL IMMUNOLOGY LABORATORY
-
批准号:2831345
-
项目类别:
-
资助金额:$95.49万
-
财政年份:1998
-
负责人:JIRI F MESTECKY
-
依托单位:
LAB TO ASSESS AIDS INDUCED MUCOSAL IMMUNE RESPONSES
-
批准号:2295814
-
项目类别:
-
资助金额:$33.43万
-
财政年份:1993
-
负责人:JIRI F MESTECKY
-
依托单位:
LAB TO ASSESS AIDS INDUCED MUCOSAL IMMUNE RESPONSES
-
批准号:2295810
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:JIRI F MESTECKY
-
依托单位:
LAB TO ASSESS AIDS INDUCED MUCOSAL IMMUNE RESPONSES
-
批准号:2295811
-
项目类别:
-
资助金额:$30.91万
-
财政年份:1993
-
负责人:JIRI F MESTECKY
-
依托单位:
海外基金